Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Stem Cell Sciences, a provider of stem cells and stem cell technologies, has signed an agreement with CHDI Foundation, a US non-profit organization pursuing treatments for Huntington's disease, to support the standardization of CHDI's novel mouse embryonic stem cell lines.
Subscribe to our email newsletter
Under the service agreement, Stem Cell Sciences (SCS) will create standard culture conditions for CHDI’s mouse embryonic stem (ES) cell lines using its serum-free and feeder-free Esgro Complete media. Financial terms have not been disclosed.
Initially, SCS will convert three cell lines to the standardized culture conditions and will monitor their viability and stability during this process. If successful, the company may have the opportunity to apply its proprietary technologies across the entire range of CHDI’s mouse ES cell lines, as well as providing the Foundation and researchers with media and reagents for future programs.
George Murphy, senior vice president of SCS, said: “Switching these cell lines to Esgro Complete media will allow researchers around the world to apply uniform media and growth conditions for easy maintenance of CHDI’s mouse model ES cell lines, removing a substantial source of experimental variability. The deal is a further validation of the quality of SCS’ media, and repeat use of CHDI’s cell lines is expected to generate further revenue growth from ESGRO Complete.”